Activation for catalysis of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus by bacterial cell wall.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of the American Chemical Society

• Publication date

  2005-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/JA0434376PMID 15713078
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.

  2004cited by this paper
• Synthesis of a fragment of bacterial cell wall.

  2004cited by this paper
• A mechanism-based inhibitor targeting the DD-transpeptidase activity of bacterial penicillin-binding proteins.

  2003cited by this paper
• The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)

  2002cited by this paper
• Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus.

  2002cited by this paper
• Evaluation of Current Methods for Detection of Staphylococci with Reduced Susceptibility to Glycopeptides

  2001cited by this paper
• A 1.2-A snapshot of the final step of bacterial cell wall biosynthesis.

  2001cited by this paper
• Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications

  1997cited by this paper

• Iterative discovery of potent polymeric antibiotics via multi-stage and multi-task learning against antimicrobial resistance

  2026cites this paper
• Resistance to Allosteric Inhibitors.

  2025cites this paper
• Adjunctive β-lactams for Staphylococcus aureus bacteremia: a narrative review

  2025cites this paper
• Elucidating allosteric signal disruption in PBP2a: impact of N146K/E150K mutations on ceftaroline resistance in methicillin-resistant Staphylococcus aureus

  2025cites this paper
• Tackling microbial resistance with 4H-chromen-4-one derivatives as a novel class of penicillin binding protein 2a inhibitors.

  2025cites this paper
• Synthesis, cytotoxic activity, molecular docking, molecular dynamics simulations, and ADMET studies of novel spiropyrazoline oxindoles based on domino Knoevenagel–Michael cyclization as potent non-toxic anticancer agents targeting β-tubulin and EGFR, with anti-MRSA activity

  2025cites this paper
• Identification of Potential PBP2a Inhibitors Against Methicillin‐Resistant Staphylococcus aureus via Drug Repurposing and Combination Therapy

  2025cites this paper
• Development of non-β-Lactam covalent allosteric inhibitors targeting PBP2a in Methicillin-Resistant Staphylococcus aureus

  2024cites this paper
• Efficacy and clinical potential of phage therapy in treating methicillin-resistant Staphylococcus aureus (MRSA) infections: A review

  2024cites this paper
• Synergistic effect of new pyrimidine derivative with oxacilin against methicillin-resistant Staphylococcus aureus.

  2024cites this paper
• Synergistic inhibition mechanism of quinazolinone and piperacillin on penicillin-binding protein 2a: a promising approach for combating methicillin-resistant Staphylococcus aureus

  2024cites this paper
• Unraveling the mechanism of ceftaroline-induced allosteric regulation in penicillin-binding protein 2a: insights for novel antibiotic development against methicillin-resistant Staphylococcus aureus

  2023cites this paper
• A Review on Five and Six-Membered Heterocyclic Compounds Targeting the Penicillin-Binding Protein 2 (PBP2A) of Methicillin-Resistant Staphylococcus aureus (MRSA)

  2023cites this paper
• The NaHCO3-Responsive Phenotype in Methicillin-Resistant Staphylococcus aureus (MRSA) Is Influenced by mecA Genotype

  2022cites this paper
• Molecular docking and proteomics reveals the synergistic antibacterial mechanism of theaflavin with β-lactam antibiotics against MRSA

  2022cites this paper
• Studies toward synthesis of the core skeleton of spiroaspertrione A

  2022cites this paper
• New sulphonamide-peptide hybrid molecules as potential PBP 2a ligands and methicillin resistant Staphylococcus aureus actives

  2022cites this paper
• Synergistic Antibacterial Activity with Conventional Antibiotics and Mechanism of Action of Shikonin against Methicillin-Resistant Staphylococcus aureus

  2022cites this paper
• Recent Advances in the Synthesis and Biological Applications of Peptidoglycan Fragments.

  2022cites this paper
• The bla and mec families of β-lactam resistance genes in the genera Macrococcus, Mammaliicoccus and Staphylococcus: an in-depth analysis with emphasis on Macrococcus.

  2022cites this paper
• Impacts of NaHCO3 on β-Lactam Binding to PBP2a Protein Variants Associated with the NaHCO3-Responsive versus NaHCO3-Non-Responsive Phenotypes

  2022cites this paper
• Medicinal Chemistry of β‐Lactam Antibiotics

  2021cites this paper
• Unconventional Antibacterials and Adjuvants.

  2021cites this paper
• A key review on oxadiazole analogs as potential methicillin-resistant Staphylococcus aureus (MRSA) activity: Structure-activity relationship studies.

  2021cites this paper
• SaccuFlow: A High-Throughput Analysis Platform to Investigate Bacterial Cell Wall Interactions.

  2021cites this paper
• On the Treatment of MRSA Skin and Soft Tissue Infection with Ceftaroline and Linezolid

  2021cites this paper
• Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design.

  2021cites this paper
• Non-β-Lactam Allosteric Inhibitors Target Methicillin-Resistant Staphylococcus aureus: An In Silico Drug Discovery Study

  2021cites this paper
• Exploration of the Structural Space in 4(3H)-Quinazolinone Antibacterials.

  2020cites this paper
• β-Lactams against the Fortress of the Gram-Positive Staphylococcus aureus Bacterium.

  2020cites this paper
• Penicillin binding protein 2a: An overview and a medicinal chemistry perspective.

  2020cites this paper
• Penicillin‐binding protein PBP2a provides variable levels of protection toward different β‐lactams in Staphylococcus aureus RN4220

  2020cites this paper
• Focusing the Lens on the CAMERA Concepts: Early Combination β-Lactam and Vancomycin Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia

  2020cites this paper
• Design, synthesis, in-silico studies and biological screening of quinazolinone analogues as potential antibacterial agents against MRSA.

  2019cites this paper
• The Quinazolinone Allosteric Inhibitor of PBP 2a Synergizes with Piperacillin and Tazobactam against Methicillin-Resistant Staphylococcus aureus

  2019cites this paper
• The Staphylococcal Cell Wall

  2019cites this paper
• Synthesis, Characterisation and Biological Evaluation of Ampicillin–Chitosan–Polyanion Nanoparticles Produced by Ionic Gelation and Polyelectrolyte Complexation Assisted by High-Intensity Sonication

  2019cites this paper
• Constructing and deconstructing the bacterial cell wall

  2019cites this paper
• The synergistic effect of PDT and oxacillin on clinical isolates of Staphylococcus aureus

  2018cites this paper
• Aspermerodione, a novel fungal metabolite with an unusual 2,6-dioxabicyclo[2.2.1]heptane skeleton, as an inhibitor of penicillin-binding protein 2a

  2018cites this paper
• Allostery, Recognition of Nascent Peptidoglycan, and Cross-linking of the Cell Wall by the Essential Penicillin-Binding Protein 2x of Streptococcus pneumoniae.

  2018cites this paper
• Genetic and Molecular Mechanisms Associated with Antibiotic Resistance in Methicillin Resistant Staphylococcus aureus (MRSA): A Review

  2018influential citation
• The identification and characterisation of novel antimicrobial resistance genes from human and animal metagenomes

  2017influential citation
• Spiroaspertrione A, a Bridged Spirocyclic Meroterpenoid, as a Potent Potentiator of Oxacillin against Methicillin-Resistant Staphylococcus aureus from Aspergillus sp. TJ23.

  2017cites this paper
• Allosteric Inhibition of Bacterial Targets: An Opportunity for Discovery of Novel Antibacterial Classes

  2017cites this paper
• Conformational Dynamics in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus, Allosteric Communication Network and Enablement of Catalysis.

  2017cites this paper
• Reconstitution of the Final Step of Peptidoglycan Assembly in Staphylococcus aureus

  2016cites this paper
• Structure–Activity Relationship for the 4(3H)-Quinazolinone Antibacterials

  2016cites this paper
• One ring to rule them all: Current trends in combating bacterial resistance to the β‐lactams

  2016cites this paper
• In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams

  2016cites this paper
• Mechanisms of Methicillin Resistance in Staphylococcus aureus.

  2015cites this paper
• The role of species-specific modifications in peptidoglycan biosynthesis

  2015cites this paper
• Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA

  2015cites this paper
• The Tipper-Strominger Hypothesis and Triggering of Allostery in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus (MRSA).

  2015cites this paper
• DIPLOMARBEIT / DIPLOMA THESIS

  2015cites this paper
• Impact of the β-Lactam Resistance Modifier (−)-Epicatechin Gallate on the Non-Random Distribution of Phospholipids across the Cytoplasmic Membrane of Staphylococcus aureus

  2015cites this paper
• The Allosteric Site for the Nascent Cell Wall in Penicillin-Binding Protein 2a: An Achilles' Heel of Methicillin-Resistant Staphylococcus aureus.

  2015cites this paper
• The β-Lactam Antibiotics: Their Future in the Face of Resistance

  2014cites this paper
• Penicillin‐binding protein 2a of methicillin‐resistant Staphylococcus aureus

  2014cites this paper
• of the ClpXP Protease aureus USA300 Is Increased by Inactivation Methicillin-Resistant Staphylococcus -Lactam Resistance in β

  2014cites this paper
• The Mechanisms of Resistance to b-Lactam Antibiotics

  2014cites this paper
• β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus USA300 Is Increased by Inactivation of the ClpXP Protease

  2014cites this paper
• How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function

  2013influential citation
• Alternative natural sources for a new generation of antibacterial agents.

  2013cites this paper
• Staphylococcus aureus : aspects of pathogenesis and molecular epidemiology

  2013cites this paper
• Overcoming resistance to β-lactam antibiotics.

  2013cites this paper
• Substrate specificity of low-molecular mass bacterial DD-peptidases.

  2011cites this paper
• A computational evaluation of the mechanism of penicillin-binding protein-catalyzed cross-linking of the bacterial cell wall.

  2011cites this paper
• Design, Synthesis, and Evaluation of Small Molecules as Potential Inhibitors of Bacterial Cell Wall Biosynthesis

  2011cites this paper
• Insertion of Epicatechin Gallate into the Cytoplasmic Membrane of Methicillin-resistant Staphylococcus aureus Disrupts Penicillin-binding Protein (PBP) 2a-mediated β-Lactam Resistance by Delocalizing PBP2

  2010cites this paper
• 8.13 – Enzymology of Bacterial Resistance

  2010cites this paper
• β-Lactam Antibiotics

  2010cites this paper
• Structural analysis of beta-lactamase and resistant transpeptidase inhibition

  2009cites this paper
• Key side products due to reactivity of dimethylmaleoyl moiety as amine protective group

  2009cites this paper
• Molecular Basis and Phenotype of Methicillin Resistance in Staphylococcus aureus and Insights into New β-Lactams That Meet the Challenge

  2009cites this paper
• Restoration of Susceptibility of Methicillin-resistant Staphylococcus aureus to β-Lactam Antibiotics by Acidic pH

  2008cites this paper
• Penicillin-binding proteins and beta-lactam resistance.

  2008cites this paper
• Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics.

  2008cites this paper
• Investigation of the mechanism of the cell wall DD-carboxypeptidase reaction of penicillin-binding protein 5 of Escherichia coli by quantum mechanics/molecular mechanics calculations.

  2008cites this paper
• Crystal structures of complexes of bacterial DD-peptidases with peptidoglycan-mimetic ligands: the substrate specificity puzzle.

  2008cites this paper
• Reactions of peptidoglycan-mimetic beta-lactams with penicillin-binding proteins in vivo and in membranes.

  2007cites this paper
• Shared functional attributes between the mecA gene product of Staphylococcus sciuri and penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.

  2007cites this paper
• Direct diazo-transfer reaction on beta-lactam: synthesis and preliminary biological activities of 6-triazolylpenicillanic acids.

  2007cites this paper
• Diversity of Penicillin-binding Proteins

  2007cites this paper
• Discrete steps in sensing of beta-lactam antibiotics by the BlaR1 protein of the methicillin-resistant Staphylococcus aureus bacterium.

  2006cites this paper
• Attenuation of penicillin resistance in a peptidoglycan O‐acetyl transferase mutant of Streptococcus pneumoniae

  2006cites this paper
• Mechanistic Basis for the Action of New Cephalosporin Antibiotics Effective against Methicillin- and Vancomycin-resistant Staphylococcus aureus*

  2006cites this paper
• Interaction between two murein (peptidoglycan) synthases, PBP3 and PBP1B, in Escherichia coli

  2006cites this paper
• Reactivity of penicillin-binding proteins with peptidoglycan-mimetic beta-lactams: what's wrong with these enzymes?

  2006cites this paper
• Thermodynamics of interactions of vancomycin and synthetic surrogates of bacterial cell wall.

  2006cites this paper
• Toward Novel Glyconjugates: Efficient Synthesis of Glycosylated 4‐Alkylidene‐‐lactams

  2006cites this paper
• β-Lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome

  2005cites this paper
• β-Lactam antibiotic resistance: a current structural perspective

  2005cites this paper
• Synthesis and Proinflammatory Properties of Muramyl Tripeptides Containing Lysine and Diaminopimelic Acid Moieties

  2005cites this paper
• Beta-lactam antibiotic resistance: a current structural perspective.

  2005cites this paper